May, 23 2016, 02:00pm EDT

Over 1,500 Organizations Call on Congress to Oppose the Trans-Pacific Partnership (TPP)
A united cross-sector movement of 1,525 civil society organizations resent a letter today urging Congress to oppose the Trans-Pacific Partnership (TPP). They highlighted for each Congress member the number of groups on the letter with supporters in their state. The letter comes the same day as the corporate lobby group "U.S. Coalition for TPP" sent its own letter to Congress in support of the trade agreement.
WASHINGTON
A united cross-sector movement of 1,525 civil society organizations resent a letter today urging Congress to oppose the Trans-Pacific Partnership (TPP). They highlighted for each Congress member the number of groups on the letter with supporters in their state. The letter comes the same day as the corporate lobby group "U.S. Coalition for TPP" sent its own letter to Congress in support of the trade agreement.
"The TPP would make it even easier to ship American jobs overseas to wherever labor is the most exploited and environmental regulations are the weakest, so it's little surprise that certain corporations support this pact," said Arthur Stamoulis, executive director of Citizens Trade Campaign, which organized the civil society letter. "Civill society is unprecedentedly united against the TPP, however, due the pact's significant threats to jobs and wages, food safety, public health and the environment. This is an outrageously bad deal for working families, and Congress needs to side with constituents over corporate interest groups on this one."
The TPP is a proposed 12-nation pact that would set rules governing approximately 40% of the global economy, with a built-in mechanism so that other countries can join over time. A recent study by the U.S. International Trade Commission (ITC) -- which has traditionally overestimated the benefits and underestimated the costs of trade proposals -- found the TPP would increase the United States' global trade deficit and lead to a meager 0.15% economic growth by the year 2032.
"Given widespread public opposition, TPP supporters are now pushing to hold a vote on the agreement after the November elections during the 'lame duck' session of Congress -- that unique moment in the political calendar when Congressional accountability to constituents is at its lowest," said Stamoulis. "The offshorers aren't fooling anyone with that timing. Americans are angry about job-killing trade agreements, and voters' memories on these types of issues aren't as short as some might hope."
A copy of the letter with the full list of signers can be found online here. Text of the letter is below:
Dear Representative/Senator:
We urge you to oppose the Trans-Pacific Partnership (TPP), a binding pact that poses significant threats to American jobs and wages, the environment, food safety and public health, and that falls far short of establishing the high standards the United States should require in a 21st Century trade agreement.
If enacted, the TPP would set rules governing approximately 40% of the global economy, and includes a "docking" mechanism through which not only Pacific Rim nations, but any country in the world, could join over time. The questions policymakers should be asking about these rules is whether, on the whole, they would create American jobs, raise our wages, enhance environmental sustainability, improve public health and advance human rights and democracy. After careful consideration, we believe you will agree, the answer to these questions is no.
Our opposition to the TPP is broad and varied. Below are just some of the likely effects of the TPP that we find deeply disturbing.
Offshoring U.S. jobs and driving down wages
The TPP would offshore more good-paying American jobs, lower wages in the jobs that are left and increase income inequality by forcing U.S. employers into closer competition with companies exploiting labor in countries like Vietnam, with workers legally paid less than 65 cents an hour, and Malaysia, where an estimated one third of workers in the country's export-oriented electronics industry are the victims of human trafficking.
The TPP replicates the investor protections that reduce the risks and costs of relocating production to low wage countries. The pro-free-trade Cato Institute considers these terms a subsidy on offshoring, noting that they lower the risk premium of relocating to venues that American firms might otherwise not consider.
And the TPP's labor standards are grossly inadequate to the task of protecting human rights abroad and jobs here at home. The countries involved in the TPP have labor and human rights records so egregious that the "May 10th" model -- which was never sufficient to tackle the systemic labor abuses in Colombia -- is simply incapable of ensuring that workers in Mexico, Vietnam, Malaysia and all TPP countries will be able to exercise the rights they are promised on paper. Even if the labor standards were much stronger, the TPP is also so poorly negotiated that it allows products assembled mainly from parts manufactured in "third party" countries with no TPP obligations whatsoever to enter the United States duty free.
The TPP contains none of the enforceable safeguards against currency manipulation demanded by a bipartisan majority in both chambers of Congress. Thus, the often modest tariff cuts achieved under the pact for U.S. exporters could be easily wiped out overnight by countries' willingness to devalue their currencies in order to gain an unfair trade advantage. Already, the TPP includes several notorious currency manipulators, and would be open for countries such as China to join.
In addition, the TPP includes procurement requirements that would waive "Buy American" and "Buy Local" preferences in many types of government purchasing, meaning our tax dollars would also be offshored rather than being invested at home to create jobs here. Even the many Chinese state-owned enterprises in Vietnam would have to be treated equally with U.S. firms in bidding on most U.S. government contracts. The pact even includes financial services provisions that we are concerned might be interpreted to prohibit many of the commonsense financial stability policies necessary to head off future economic crises. The TPP is a major threat to the U.S. and global economy alike.
Undermining environmental protection
The TPP's Environment Chapter rolls back the initial progress made in the "May 10th" agreement between congressional Democrats and President George W. Bush with respect to multilateral environmental (MEAs) agreements. The TPP only includes an obligation to "adopt, maintain, and implement" domestic policies to fulfill one of the seven MEAs covered by Bush-era free trade agreements and listed in the "Fast Track" law. This omission would allow countries to violate their obligations in key environmental treaties in order to boost trade or investment without any consequences.
Of the new conservation measures in the TPP, most have extremely weak obligations attached to them, requiring countries to do things such as "exchange information and experiences" and "endeavor not to undermine" conservation efforts, rather than requiring them to "prohibit" and "ban" destructive practices. This stands in stark contrast to many of the commercial obligations found within the agreement.
The TPP's controversial investor-state dispute settlement (ISDS) system would enable foreign investors to challenge bedrock environmental and public health laws, regulations and court decisions as violations of the TPP's broad foreign investor rights in international tribunals that circumvent domestic judicial systems -- a threat felt at home and throughout the Pacific Rim.
Despite the fact that the TPP could threaten climate policies, increase shipping emissions and shift U.S. manufacturing to more carbon-intensive countries, the TPP fails to even include the words "climate change."
Jeopardizing the safety of the food we feed our families
The TPP includes language not found in past pacts that allows exporters to challenge border food safety inspection procedures. This is a dire concern given the TPP includes countries such as Vietnam and Malaysia that export massive quantities of shrimp and other seafood to the United States, significant amounts of which are now rejected as unsafe under current policies.
As well, new language in the final text replicates the industry demand for a so-called "Rapid Response Mechanism" that requires border inspectors to notify exporters for every food safety check that finds a problem and give the exporter the right to bring a challenge to that port inspection determination. This is a new right to bring a trade challenge to individual border inspection decisions (including potentially laboratory or other testing) that second-guesses U.S. inspectors and creates a chilling effect that would deter rigorous oversight of imported foods.
The TPP additionally includes new rules on risk assessment that would prioritize the extent to which a food safety policy impacts trade, not the extent to which it protects consumers.
Rolling back access to life-saving medications
Many of the TPP's intellectual property provisions would effectively delay the introduction of low-cost generic medications, increasing health care prices and reducing access to medicine both at home and abroad.
Pharmaceutical firms obtained much of their agenda in the TPP. This includes new monopoly rights that do not exist in past agreements with respect to biologic medicines, a category that includes cutting edge cancer treatments. The TPP also contains requirements that TPP nations allow additional 20-year patents for new uses of drugs already under patent, among other rules that would promote the "evergreening" of patent monopolies. Other TPP provisions may enable pharmaceutical companies to challenge Medicare drug listing decisions, Medicaid reimbursements and constrain future U.S. policy reforms to reduce healthcare costs.
With this agreement, the United States would shamefully roll back some of the hard-fought protections for access to medicine in trade agreements that were secured during the George W. Bush administration. Indeed, the pact eviscerates the core premise of the "May 10th" reforms that poor nations require more flexibility in medicine patent rules so as to ensure access. All of the TPP's extreme medicine patent rules will apply equally to developing countries with only short transition periods for application of some of the rules.
Elevating investor rights over human rights and democracy
Contrary to Fast Track negotiating objectives, the TPP's Investment Chapter and its ISDS system would grant foreign firms greater rights than domestic firms enjoy under U.S. law. One class of interests -- foreign firms -- could privately enforce this public treaty by skirting domestic laws and courts to challenge U.S. federal, state and local decisions and policies on grounds not available in U.S. law and do so before extrajudicial tribunals authorized to order payment of unlimited sums of taxpayer dollars. Under the TPP, compensation orders could include the "expected future profits" a tribunal determines that an investor would have earned in the absence of the public policy it is attacking.
Worse, the TPP would expand U.S. ISDS liability by widening the scope of domestic policies and government actions that could be challenged. For the first time in any U.S. free trade agreement, the provision used in most successful investor compensation demands would be extended to challenges of financial regulatory policies. The TPP would extend the "minimum standard of treatment" obligation to the TPP's Financial Services Chapter's terms, allowing financial firms to challenge policies as violating investors' "expectations" of how they should be treated. Meanwhile, the "safeguard" that the U.S. Trade Representative (USTR) claims would protect such policies merely replicates terms that have failed to protect challenged policies in the past.
In addition, the TPP would newly allow pharmaceutical firms to use the TPP to demand cash compensation for claimed violations of World Trade Organization (WTO) rules on creation, limitation or revocation of intellectual property rights. Currently, WTO rules are not privately enforceable by investors.
With Japanese, Australian and other firms newly empowered to launch ISDS attacks against the United States, the TPP would double U.S. ISDS exposure. More than 1,000 additional corporations in TPP nations, which own more than 9,200 subsidiaries here, could newly launch ISDS cases against the U.S. government. About 1,300 foreign firms with about 9,500 U.S. subsidiaries are so empowered under all existing U.S. investor-state-enforced pacts. Most of these are with developing nations with few investors here. That is why, until the TPP, the United States has managed largely to dodge ISDS attacks to date.
In these, and multiple other ways, the TPP elevates investor rights over human rights and democracy, threatening an even broader array of public policy decisions than described above. This, unfortunately, is the all-too-predictable result of a secretive negotiating process in which hundreds of corporate advisors had privileged access to negotiating texts, while the public was barred from even reviewing what was being proposed in its name.
The TPP does not deserve your support. Had Fast Track not become law, Congress could work to remove the misguided and detrimental provisions of the TPP, strengthen weak ones and add new provisions designed to ensure that our most vulnerable families and communities do not bear the brunt of the TPP's many risks. Now that Fast Track authority is in place for it, Congress is left with no means of adequately amending the agreement without rejecting it entirely. We respectfully ask that you do just that.
Thank you for your consideration. We will be following your position on this matter closely.
Sincerely,
Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.
(202) 588-1000LATEST NEWS
Dems Demand Answers as Trump Photo Disappears From DOJ Online Epstein Files
"What else is being covered up?"
Dec 20, 2025
Congressional Democrats on Saturday pressed US Attorney General Pam Bondi for answers regarding the apparent removal of a photo showing President Donald Trump surrounded by young female models from Friday's Department of Justice release of files related to the late convicted child sex criminal Jeffrey Epstein.
Amid the heavily redacted documents in Friday's DOJ release was a photo of a desk with an open drawer containing multiple photos of Trump, including one of him with Epstein and convicted child sex trafficker Ghislaine Maxwell and another of him with the models.
However, the photo—labeled EFTA00000468 in the DOJ's Epstein Library—was no longer on the site as of Saturday morning.
"This photo, file 468, from the Epstein files that includes Donald Trump, has apparently now been removed from the DOJ release," Democrats on the House Oversight Committee noted in a Bluesky post. "AG Bondi, is this true? What else is being covered up? We need transparency for the American public."
This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release.AG Bondi, is this true? What else is being covered up? We need transparency for the American public.
[image or embed]
— Oversight Dems (@oversightdemocrats.house.gov) December 20, 2025 at 9:30 AM
Numerous critics have accused the Trump administration of a cover-up due to the DOJ's failure to meet a Friday deadline to release all Epstein-related documents and heavy redactions—including documents of 100 pages or more that are completely blacked out—to many of the files.
Deputy Attorney General Todd Blanche responded to the criticism by claiming that "the only redactions being applied to the documents are those required by law—full stop."
"Consistent with the statute and applicable laws, we are not redacting the names of individuals or politicians unless they are a victim," he added.
Earlier this year, officials at the Federal Bureau of Investigation reportedly redacted Trump's name from its file on Epstein, who was the president's longtime former friend and who died in 2019 in a New York City jail cell under mysterious circumstances officially called suicide while facing federal child sex trafficking and conspiracy charges.
Trump has not been accused of any crimes in connection with Epstein.
House Oversight Committee Ranking Member Robert Garcia (D-Calif.) said during a Friday CNN interview that the DOJ only released about 10% of the full Epstein files.
The DOJ is breaking the law by not releasing the full Epstein files. This is not transparency. This is just more coverup by Donald Trump and Pam Bondi. They need to release all the files, NOW.
[image or embed]
— Congressman Robert Garcia (@robertgarcia.house.gov) December 19, 2025 at 5:06 PM
"The DOJ has had months and hundreds of agents to put these files together, and yet entire documents are redacted—from the first word to the last," Garcia said on X. "What are they hiding? The American public deserves transparency. Release all the files now!"
In a joint statement Friday, Garcia and House Judiciary Committee Ranking Member Jamie Raskin (D-Md.) said, "We are now examining all legal options in the face of this violation of federal law."
"The survivors of this nightmare deserve justice, the co-conspirators must be held accountable, and the American people deserve complete transparency from DOJ," they added.
Rep. Ro Khanna (D-Calif.)—who along with Rep. Thomas Massie (R-Ky.) introduced the Epstein Files Transparency Act, which was signed into law by Trump last month and required the release of all Epstein materials by December 19—said in a video published after Friday's document dump that he and Massie "are exploring all options" to hold administration officials accountable.
"It can be the impeachment of people at Justice, inherent contempt, or referring for prosecution those who are obstructing justice," he added.
Keep ReadingShow Less
Israeli Forces Massacre 6 Palestinians Celebrating Wedding at Gaza School Shelter
"This isn't a truce, it's a bloodbath," said a relative of some of the victims, who included women, an infant, and a teenage girl.
Dec 20, 2025
Funerals were held Saturday in northern Gaza for six people, including children, massacred the previous day by Israeli tank fire during a wedding celebration at a school sheltering displaced people, as the number of Palestinians killed during the tenuous 10-week ceasefire rose to over 400.
On Friday, an Israel Defense Forces (IDF) tank blasted the second floor of the Gaza Martyrs School, which was housing Palestinians displaced by the two-year war on Gaza in the al-Tuffah neighborhood of Gaza City.
Al Jazeera and other news outlets reported that the attack occurred while people were celebrating a wedding.
Al-Shifa Hospital director Mohammed Abou Salmiya said those slain included a 4-month-old infant, a 14-year-old girl, and two women. At least five others were injured in the attack.
"It was a safe area and a safe school and suddenly... they began firing shells without warning, targeting women, children and civilians," Abdullah Al-Nader—who lost relatives including 4-month-old Ahmed Al-Nader in the attack—told Agence France-Presse.
Witnesses said IDF troops subsequently blocked first responders including ambulances and civil defense personnel from reaching the site for over two hours.
"We gathered the remains of children, elderly, infants, women, and young people," Nafiz al-Nader, another relative of the infant and others killed in Friday's attack, told reporters. "Unfortunately, we called the ambulance and the civil defense, but they couldn't get by the Israeli army."
The IDF said that “during operational activity in the area of the Yellow Line in the northern Gaza Strip, a number of suspicious individuals were identified in command structures," and that "troops fired at the suspicious individuals to eliminate the threat."
The Yellow Line is a demarcation boundary between areas of Gaza under active Israeli occupation—more than half of the strip's territory, including most agricultural and strategic lands—and those under the control of Hamas.
"The claim of casualties in the area is familiar; the incident is under investigation," the IDF said, adding that it "regrets any harm to uninvolved parties and acts as much as possible to minimize harm to them."
Since the October 7, 2023 Hamas-led attack on Israel, more than 250,000 Palestinians have been killed or wounded by Israeli forces, including approximately 9,500 people who are missing and presumed dead and buried beneath rubble. Classified IDF documents suggest that more than 80% of the Palestinians killed by Israeli forces were civilians.
Around 2 million Palestinians have also been displaced—on average, six times—starved, or sickened in the strip.
Gaza officials say at least 401 Palestinians have been killed since a US-brokered ceasefire between Israel and Hamas took effect on October 10. Gaza's Government Media Office says Israel has violated the ceasefire at least 738 times.
"This isn't a truce, it's a bloodbath," Nafiz al-Nader told Agence France-Presse outside al-Shifa Hospital on Saturday.
Israel says Hamas broke the truce at least 32 times, with three IDF soldiers killed during the ceasefire.
Israeli Prime Minister Benjamin Netanyahu and Yoav Gallant, his former defense minister, are fugitives from the International Criminal Court in The Hague, where they are wanted for alleged war crimes and crimes against humanity in Gaza, including murder and forced starvation.
Israel is also facing a genocide case filed by South Africa at the International Court of Justice, also in The Hague. A United Nations commission, world leaders, Israeli and international human rights groups, jurists, and scholars from around the world have called Israel's war on Gaza a genocide.
Friday's massacre came as Steve Witkoff, President Donald Trump's Mideast envoy, other senior US officials, and representatives of Egypt, Qatar, Turkey, and the United Arab Emirates met in Miami to discuss the second phase of Trump's peace plan, which includes the deployment of an international stabilization force, disarming Hamas, the withdrawal of IDF troops from the strip, and the establishment of a new government there.
Keep ReadingShow Less
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Most Popular


